The company GenBioPro alleges that the US Food and Drug Administration has violated the Constitution’s Due Process Clause and other laws in how the agency has responded to recent court orders halting the approval of the generic version of the drug, mifepristone. GenBioPro is seeking a court order that would require the FDA to go through certain procedural steps laid out under federal law before declaring its mifepristone product unapproved.
The new lawsuit provides a behind-the-scenes view of the fallout from the anti-abortion litigation in Texas. The complaint zeroes in on how the federal government has said in court filings in that case that recent court orders have the effect of making GenBioPro’s product “”misbranded” and leave the generic version of the drug “without an effective drug approval.
Hello 👋🏻 Bet is ready. All those interested please write to me.. The information is limited for FREE, only a few people can accept it... Respect✊🏻 PM me!!
Imagine thinking this is a functional form of government and that courts don't have WAY too much power (and yes I'm pro choice)
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: nbcsandiego - 🏆 524. / 51 Read more »
Source: washingtonpost - 🏆 95. / 72 Read more »